These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19097882

  • 1. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, van der Linden Y, Ma B, Castro M, Arnalot PF, Ahmedzai S, Clemons M, Hoskin P, Yee A, Brundage M, Bottomley A, EORTC Quality of Life Group.
    Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
    [Abstract] [Full Text] [Related]

  • 2. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A, European Organization for Research Treatment of Cancer Quality of Life Group.
    Cancer; 2012 Mar 01; 118(5):1457-65. PubMed ID: 21837676
    [Abstract] [Full Text] [Related]

  • 3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB.
    Eur J Cancer; 2012 Sep 01; 48(14):2203-11. PubMed ID: 22572480
    [Abstract] [Full Text] [Related]

  • 4. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY, Pakpour AH.
    Asian Pac J Cancer Prev; 2016 Sep 01; 17(3):1405-10. PubMed ID: 27039780
    [Abstract] [Full Text] [Related]

  • 5. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E, Bottomley A.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct 01; 9(5):461-5. PubMed ID: 19817529
    [Abstract] [Full Text] [Related]

  • 6. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C, Fitzsimmons D, Gilbert J, Arrarras JI, Hammerlid E, Bredart A, Ozmen M, Dilektasli E, Coolbrandt A, Kenis C, Young T, Chow E, Venkitaraman R, Howse F, George S, O'Connor S, Yadegarfar G, EORTC Quality of Life Group.
    Eur J Cancer; 2010 Aug 01; 46(12):2242-52. PubMed ID: 20580993
    [Abstract] [Full Text] [Related]

  • 7. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N, Wilke J, Reschke D, Kaiser F, Schmoor C, Grugel R, Boller E.
    J Med Econ; 2018 Sep 01; 21(9):920-929. PubMed ID: 29874105
    [Abstract] [Full Text] [Related]

  • 8. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Radiother Oncol; 2016 May 01; 119(2):208-12. PubMed ID: 27157890
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G, Zeng L, Poon M, Lam H, Lauzon N, Chow E.
    Asia Pac J Clin Oncol; 2014 Jun 01; 10(2):118-23. PubMed ID: 23551978
    [Abstract] [Full Text] [Related]

  • 10. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
    Satoh T, Kobayashi K, Hori T, Iida S, Sato A, Ishiguro H, Chow E, Shimozuma K.
    Gan To Kagaku Ryoho; 2010 Aug 01; 37(8):1507-12. PubMed ID: 20716876
    [Abstract] [Full Text] [Related]

  • 11. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L, Chow E, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bedard G, Bottomley A.
    Support Care Cancer; 2012 Dec 01; 20(12):3307-13. PubMed ID: 22562607
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr 01; 12(2):213-9. PubMed ID: 22458622
    [Abstract] [Full Text] [Related]

  • 13. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
    Zhang L, Su YJ, Chen JY, Liao ZC, Luo ZQ, Xie SM, Zhang J, Lin YS, Guo H, Sun WL, Pekbay B, Miller AR, Luo L, Rui YH, Li MH, Wang CL.
    Support Care Cancer; 2016 Mar 01; 24(3):1019-24. PubMed ID: 26245496
    [Abstract] [Full Text] [Related]

  • 14. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
    Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska IM, Głowacki R, Bereza K, Golec EB, Chow E, Krzemieniecki K.
    Qual Life Res; 2014 Mar 01; 23(2):527-32. PubMed ID: 23912854
    [Abstract] [Full Text] [Related]

  • 15. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar R, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Support Care Cancer; 2016 Dec 01; 24(12):4871-4878. PubMed ID: 27465049
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing health related quality of life in cancer patients with bone metastases.
    Wong E, Chow E, Zhang L, Bedard G, Lam K, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A.
    J Palliat Med; 2013 Aug 01; 16(8):915-21. PubMed ID: 23819731
    [Abstract] [Full Text] [Related]

  • 17. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M, Sezer O, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jan 01; 43(1):87-94. PubMed ID: 17081744
    [Abstract] [Full Text] [Related]

  • 18. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group.
    Eur J Cancer; 2004 Nov 01; 40(16):2439-44. PubMed ID: 15519517
    [Abstract] [Full Text] [Related]

  • 19. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Brundage M.
    Qual Life Res; 2016 Oct 01; 25(10):2535-2541. PubMed ID: 27138964
    [Abstract] [Full Text] [Related]

  • 20. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
    Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.
    Qual Life Res; 2014 Apr 01; 23(3):825-36. PubMed ID: 24026634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.